## Note
nid: 1503708200938
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step1_v11::#Pixorize::01_Immunology::07_Leukemias_&_Lymphomas::03_CML, #AK_Step2_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step2_v11::!Shelf::IM, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian, #AK_Step2_v11::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki, #AK_Step2_v11::#Subjects::Hematology::03_WBC::04_Myeloproliferative_Disorders::Chronic_Myeloid_Leukemia, #AK_Step2_v11::Original_decks::Dorian::im::uw::heme/onc, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::HemeOnc
markdown: false

### Text
What is the <i>first-line treatment</i> for most patients with
<b>chronic myeloid leukemia</b> (CML)?
<div>
  {{c1::Tyrosine kinase inhibitors (e.g. imatinib)}}
</div>

### Extra
<i>since the Bcr-Abl fusion gene produces a tyrosine kinase
protein</i>
<div><img src="paste-5473403242807297.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

